Chronic heart failure: actual aspects of treatment in real clinical practice-Reference-Cited by-同舟云学术

Chronic heart failure: actual aspects of treatment in real clinical practice

Published:2019-10-09 Issue:16 Volume: Page:50-58
ISSN:2658-5790
Container-title:Medical Council
language:
Short-container-title:Medicinskij sovet

Author:

Trukhan D. I.¹^ORCID,Davydov E. L.²^ORCID

Affiliation:

1. Omsk State Medical University

2. Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky

Abstract

An urgent public health problem is the optimization of drug therapy in patients with chronic heart failure.A large number of works devoted to the treatment of chronic heart failure form the point of view that about the treatment of chronic heart failure «all is well known for a long time.» However, in real clinical practice, especially at the stage of primary health care, for various reasons, possible pitfalls, reefs and shallows are not taken into account, the underestimation of which can introduce certain difficulties and cause the treatment of patients with chronic heart failure to be ineffective.The review article examined a number of important aspects of the treatment of chronic heart failure, which, for various reasons, are underestimated in the supervision of patients. First of all, this refers to antagonists of mineralocorticoid receptors, in particular to spironolactone, and an inhibitor of If - channels of the sinus node ivabradine.The results of foreign and Russian studies, modern recommendations for the supervision of patients with chronic heart failure, indicate that the presence of spironolactone and ivabradine in the arsenal of a practical doctor allows optimizing drug therapy in patients with chronic heart failure and increasing its effectiveness.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference71 articles.

1. Demographic Yearbook of Russia. 2013. (In Russ.) Available at: http://www.gks.ru/bgd/regl/ B13_16/Main.htm.

2. Trukhan D.I. Treatment of chronic heart failure and arterial hypertension: two aims and one drug - torasemide. Consilium Medicum. 2017;19(10):79–84. (In Russ.) Available at: https://elibrary.ru/item.asp?id=30476475.

3. Trukhan D.I. Treatment of chronic heart failure and arterial hypertension: two aims and one drug - fosinopril. Consilium Medicum. 2018;(05):50-55. (In Russ.) doi: 10.26442/2075- 1753_2018.5.50-55.

4. Russian Cardiology Society. Society of Heart Failure Specialists. Clinical recommendations. Chronic heart failure (CHF). 2016. (In Russ.) Available at: http://ossn.ru/upload/medialibrary/003/97_30012017.pdf.

5. Fomin I.V. Chronic heart failure in Russian Federation: what do we know and what to do. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2016;(8):7-13. (In Russ.) https://doi.org/10.15829/1560-4071-2016-8-7-13. 6. Mareev V.Yu., Ageev F.T., Arutyunov G.P., Koroteev A.V., Mareev Yu.V., Ovchinnikov A.G., Belenkov Yu.N., Vasyuk Yu.A., Galyavich A .S., Garganeeva A.A., Gilyarevsky S.R., Glezer M.G., Koziolova N.A., Kots Y.I., Lopatin Yu.M., Martynov A.I., Moiseev V.S., Revishvili A.Sh., Sitnikova M.Yu., Skibitsky V.V. National recommendations of the OSCH, RKO and RNMOT for the diagnosis and treatment of heart failure (fourth revision). Serdechnaya Nedostatochnost’ = Russian Heart Failure Journal. 2013;14(7):379-472. (In Russ.) Available at: https://docplayer.ru/25808031-Mareev-v-yu1-ageev-f-t-1-arutyunov-g-p-1-koroteev-a-v1-mareev-yu-v-3-ovchinnikov-a-g-4.html.